Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-05T08:55:28.653Z Has data issue: false hasContentIssue false

Psychiatric Uses of Meratran

Published online by Cambridge University Press:  08 February 2018

A. G. Fullerton*
Affiliation:
Herrison Hospital, Dorchester

Extract

Meratran (alpha-2-piperidyl benzhydrol hydrochloride) is a cerebral stimulant with an action not unlike the amphetamine series but differing in other respects in that it does not interfere with sleep, nor appetite, nor is its use followed by depression. It is not apparently a sympathomimetic drug, since it does not cause any marked cardiovascular pressor effects. Recent reports from America (1) have suggested that the drug is of use in treating patients suffering from depression and psychomotor retardation either due to mental illness, fatigue or a side-effect of other drugs, e.g. chlorpromazine or reserpine.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1956 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. SCHUT, J. W., and Himwich, H. E., “The effect of Meratran on twenty-five institutionalized mental patients”, Amer. J. Psychiatry, 1955, 111, No. 11.Google Scholar
2. Fabing, H. D., A paper read before a joint meeting of the Texas and Mexican Neuropsychiatric Societies, Galveston, Texas, October, 1955.Google Scholar
3. Forster, M. B., et al., “The clinical effects of (alpha (2 piperidyl) benzhydrol hydrochloride) (Meratran) in states of inactivity in elderly psychiatric patients”, Canad. M.A.J., 1955, 72, 678.Google Scholar
4. Pomeranze, J., “A new antidepressant in geriatrics”, J. Gerontology, 1954, 9, 486.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.